Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
Mayo Clinic-Promega-QuantumCyte AMP 2024 Poster
Enhanced MSI Status Determination from FFPE Tissue Sections Using an Integrated Workflow Combining QuantumCyte's QCPRECISE! with Promega's Maxwell® CSC DNA FFPE Kit
SGH and QuantumCyte-USCAP 2024
A Novel Tissue Masking Technology Successfully Improves Tumor Cellularity for
Clinical Next Generation Sequencing – Early Results of a Clinical Validation Study
Mayo Clinic and QuantumCyte-USCAP2024
Using artificial intelligence to perform spatial gene expression profiling of colorectal carcinoma using a novel, high resolution,
ink-based on-slide printing technology from Quantumcyte, QCPRECISE!
Mayo Clinic and QuantumCyte-AMP 2023
QCPRECISE! A Novel Spatially Targeted Tissue Microdissection Platform Driven by AI Guided Digital Pathology
Imaging Improves Extracted Solid Tumor DNA Purity Relative to Conventional Macrodissection.
REVEAL Biosciences and QuantumCyte
A Novel AI-driven Spatial Genomics Platfrom Demonstrates Heterogeneity in NASH Liver
Singapore General Hospital and QuantumCyte
An automated tissue dissection platform improves NGS data quality of clinical lung and colon cancer biopsies.
SingHealth Duke NUS and QuantumCyte
The Tumour Immune Microenvironment of Recurrent/Metastatic Nasopharyngeal Carcinoma
FFPE H&E stained sections on slides are Digitally or AI Annotated and the resulting JSON file is uploaded to QCPRECISE!™ PRINTMATCH™ Software. QCPRECISE!™ is agnostic to the Annotation platform.
The QCPRECISE!™ instrument in action. The QCPRECISE!™ instrument uses the Masking file to deposit a proprietary polymer on the tissue areas that are not the regions of interest.
Pre-Masked Regions of Interest/Tumor are show in dark purple.
Masking and Lysis of the tissue in the Regions of Interest is done on the slide. Tumor tissue is precisely removed and the Lysate is purified while the background tissue is blocked by the poylmer mask.
Nucleic Acid Purification of RNA or DNA from Lysate can be performed and used for Molecular Testing. Results in increased Purity of Nucleic Acids from Region of Interest/Tumor.
Get Early access to the QCPRECISE!™ Platform
Contact us to apply to participate in our
Early Access Program
Publications and Posters
Mayo Clinic_QuantumCyte_USCAP 2024_Poster (pdf)
DownloadSingapore General Hospital_Quantumcyte_USCAP 2024 Poster (pdf)
DownloadQC/Mayo-DNA Purity Comparison-AMP 2023 Poster (pdf)
DownloadQC/Reveal Bio/Ochre-NASH (pdf)
DownloadQC/Singapore General-Lung and Colon Cancer (pdf)
DownloadQC/SingHealth/DukeNUS-Metastatic Carcinoma Study (pdf)
DownloadCopyright © 2024 QuantumCyte - All Rights Reserved.
Powered by GoDaddy